Coriolis Pharma

Coriolis Pharma is a globally recognized, science-driven contract research and development organization (CRDO) dedicated to advancing drug product development for biopharmaceuticals, including innovative gene and cell therapies, as well as vaccines, from the earliest stages of development through to successful commercialization. Coriolis Pharma excels in providing comprehensive support, focusing on formulation development, advanced lyophilization technologies, and robust analytics under both GMP and non-GMP conditions, catering to a diverse array of products.

Located at Fraunhoferstr. 18 b, Martinsried (Munich), Bavaria 82152, DE, Coriolis Pharma operates as a privately held and independent entity, fostering an environment of innovation and collaboration. Our interdisciplinary team comprises highly skilled scientists and benefits from the guidance of an expert scientific advisory board, ensuring that we deliver cutting-edge services and tailor-made solutions to meet the unique needs of our clients. Coriolis Pharma is committed to excellence and scientific rigor, ensuring the highest quality outcomes for every project.

Coriolis Pharma offers an extensive selection of services meticulously designed for all types of biopharmaceuticals, encompassing proteins, peptides, nucleic acids, gene- and cell therapy products, vaccines, and virus(-like) particles up to biosafety level S2. We invite the management team at Coriolis Pharma to create a customized and exclusive company showcase and product listing on our platform to further highlight your exceptional capabilities and services.